Aclaris Therapeutics, Inc. (ACRS)
Share Price Chart
Loading data...
Performance
The chart shows the growth of $10,000 invested in Aclaris Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $7,195 for a total return of roughly -28.05%. All prices are adjusted for splits and dividends.
Compare to other instruments
Return
Aclaris Therapeutics, Inc. had a return of -49.52% year-to-date (YTD) and -52.93% in the last 12 months. Over the past 10 years, Aclaris Therapeutics, Inc. had an annualized return of -4.33%, while the S&P 500 had an annualized return of 9.62%, indicating that Aclaris Therapeutics, Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | -39.45% | -3.13% |
| Year-To-Date | -49.52% | 2.92% |
| 6 months | -40.98% | 2.02% |
| 1 year | -52.93% | -11.46% |
| 5 years (annualized) | -15.06% | 7.79% |
| 10 years (annualized) | -4.33% | 9.62% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 7.30% | -26.27% | ||||||||||
| 2022 | -1.07% | -0.83% | -2.50% | 3.48% |
Dividend History
Aclaris Therapeutics, Inc. doesn't pay dividends
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Aclaris Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Aclaris Therapeutics, Inc. is 97.73%, recorded on Mar 18, 2020. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.73% | Apr 18, 2017 | 735 | Mar 18, 2020 | — | — | — |
| -49.56% | Dec 23, 2015 | 63 | Mar 24, 2016 | 173 | Nov 29, 2016 | 236 |
| -19.68% | Dec 19, 2016 | 34 | Feb 7, 2017 | 13 | Feb 27, 2017 | 47 |
| -13.11% | Nov 24, 2015 | 7 | Dec 3, 2015 | 9 | Dec 16, 2015 | 16 |
| -12.04% | Mar 7, 2017 | 11 | Mar 21, 2017 | 18 | Apr 17, 2017 | 29 |
| -8.38% | Oct 13, 2015 | 1 | Oct 13, 2015 | 1 | Oct 14, 2015 | 2 |
| -8.03% | Oct 16, 2015 | 9 | Oct 28, 2015 | 9 | Nov 10, 2015 | 18 |
| -6.87% | Dec 7, 2016 | 5 | Dec 13, 2016 | 3 | Dec 16, 2016 | 8 |
| -3.96% | Feb 28, 2017 | 3 | Mar 2, 2017 | 1 | Mar 3, 2017 | 4 |
| -3.93% | Nov 11, 2015 | 1 | Nov 11, 2015 | 2 | Nov 13, 2015 | 3 |
Volatility Chart
Current Aclaris Therapeutics, Inc. volatility is 52.39%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.